Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Queensland Health
Colorcon
Accenture
Covington
Novartis
Medtronic
Teva
Merck
Fuji
Citi

Generated: October 24, 2017

DrugPatentWatch Database Preview

SIRTURO Drug Profile

« Back to Dashboard

Which patents cover Sirturo, and what generic Sirturo alternatives are available?

Sirturo is a drug marketed by Janssen Therap and is included in one NDA. There are two patents protecting this drug.

This drug has ninety-three patent family members in thirty-nine countries and twelve supplementary protection certificates in nine countries.

The generic ingredient in SIRTURO is bedaquiline fumarate. One supplier is listed for this compound. Additional details are available on the bedaquiline fumarate profile page.

Summary for Tradename: SIRTURO

US Patents:2
Applicants:1
NDAs:1
Suppliers / Packagers: see list1
Bulk Api Vendors: see list22
Clinical Trials: see list5
Formulation / Manufacturing:see details
Drug Prices:see details
DailyMed Link:SIRTURO at DailyMed

Pharmacology for Tradename: SIRTURO

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Janssen Therap
SIRTURO
bedaquiline fumarate
TABLET;ORAL204384-001Dec 28, 2012RXYesYes► Subscribe► SubscribeYY ► Subscribe
Janssen Therap
SIRTURO
bedaquiline fumarate
TABLET;ORAL204384-001Dec 28, 2012RXYesYes► Subscribe► Subscribe► Subscribe
Janssen Therap
SIRTURO
bedaquiline fumarate
TABLET;ORAL204384-001Dec 28, 2012RXYesYes► Subscribe► SubscribeYY ► Subscribe
Janssen Therap
SIRTURO
bedaquiline fumarate
TABLET;ORAL204384-001Dec 28, 2012RXYesYes► Subscribe► SubscribeYY ► Subscribe
Janssen Therap
SIRTURO
bedaquiline fumarate
TABLET;ORAL204384-001Dec 28, 2012RXYesYes► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

International Patent Family for Tradename: SIRTURO

Country Document Number Estimated Expiration
Peru13502008► Subscribe
SloveniaEP1527050► Subscribe
Poland375523► Subscribe
TaiwanI417098► Subscribe
Israel199077► Subscribe
Canada2493225► Subscribe
Japan2010511663► Subscribe
Eurasian Patent Organization008937► Subscribe
South Africa200903907► Subscribe
Hong Kong1214513► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Due to the complexity of determining patent expirations even in a single country, compounded by the diversity of global patent laws, it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

Supplementary Protection Certificates for Tradename: SIRTURO

Supplementary Protection Certificate SPC Country SPC Expiration SPC Description
520Luxembourg► SubscribePRODUCT NAME: BEDAQUILINE, OU SON SEL D ADDITION D ACIDE OU DE BASE PHARMACEUTIQUEMENT ACCEPTABLE, Y COMPRIS LE FUMARATE DE BEDAQUILINE. FIRST REGISTRATION: 20140307
C0060France► SubscribePRODUCT NAME: BEDAQUILINE OU UN DE SES SELS D'ADDITION D'ACIDE OU DE BASE PHARMACEUTIQUEMENT ACCEPTABLE, Y COMPRIS LE FUMARATE DE BEDAQUILINE; REGISTRATION NO/DATE: EU/1/13/901 20140307
00684Netherlands► SubscribePRODUCT NAME: BEDAQUILINE, OF EEN FARMACEUTISCH AANVAARDBAAR ZUUR- OF BASE-ADDITIEZOUT DAARVAN, WAARONDER BEDAQUILINEFUMARAAT; REGISTRATION NO/DATE: EU/1/13/901 20140307
14/045Ireland► SubscribePRODUCT NAME: BEDAQUILINE, OR A PHARMACEUTICALLY ACCEPTABLE ACID OR BASE ADDITION SALT THEREOF, INCLUDING BEDAQUILINE FUMARATE; REGISTRATION NO/DATE: EU/1/13/901 20140305
0140026 00112Estonia► SubscribePRODUCT NAME: BEDAKVILIIN;REG NO/DATE: K(2014)1616 (LOPLIK) 07.03.2014
2014032,C1527050Lithuania► SubscribePRODUCT NAME: BEDAQUILINUM; REGISTRATION NO/DATE: EU/1/13/901 20140305
2014 00044Denmark► SubscribePRODUCT NAME: BEDAKILIN ELLER ET FARMACEUTISK ACCEPTABELT SYRE- ELLER BASEADDITIONSSALT DERAF, HERUNDER BEDAKILINFUMARAT; REG. NO/DATE: EU/1/13/901 20140305
0684Netherlands► SubscribePRODUCT NAME: BEDAQUILINE, OF EEN FARMACEUTISCH AANVAARDBAAR ZUUR- OF BASE-ADDITIEZOUT DAARVAN, WAARONDER BEDAQUILINEFUMARAAT; REGISTRATION NO/DATE: EU/1/13/901 20140307
2014 00044Denmark► SubscribePRODUCT NAME: BEDAKILIN ELLER ET FARMACEUTISK ACCEPTABELT SYRE-ELLER BASEADDITIONSSALT DERAF, HERUNDER BEDAKILINFUMARAT; REG. NO/DATE: EU/1/13/901 20140305
90050-0Sweden► SubscribePRODUCT NAME: BEDAQUILINE, OR A PHARMACEUTICALLY ACCEPTABLE ACID OR BASE ADDITION SALT THEREOF, INCLUDING BEDAQUILINE FUMARATE; REG. NO/DATE: EU/1/13/901 20140305
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

Argus Health
Chinese Patent Office
Boehringer Ingelheim
Cipla
Mallinckrodt
UBS
McKesson
Julphar
Chubb
Express Scripts

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot